https://nova.newcastle.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:51281 Wed 30 Aug 2023 09:59:56 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:36396 Wed 28 Feb 2024 14:54:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:24547 Wed 23 Feb 2022 16:05:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:37175 Wed 23 Feb 2022 16:05:04 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:48591 Wed 22 Mar 2023 08:39:40 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:35975 Diagnostic and Statistical Manual of Mental Disorders (4th ed.) anxiety disorder. Participants were 193 children from urban Sydney, Australia, who were block-randomized to a 10-week group-based program of ACT or CBT or a 10-week waitlist control (WLC). Completers included 157 children (ACT = 54, CBT = 57, WLC = 46; M = 11 years, SD = 2.76; 78% Caucasian, 58% female). Pretreatment, posttreatment, and 3 months posttreatment assessments included clinician/self/parent-reported measures of anxiety, quality of life (QOL; anxiety interference, psychosocial and physical health-related QOL), and acceptance/defusion outcomes. Completer and intention-to-treat analyses revealed that ACT and CBT were both superior to WLC across outcomes, reflecting statistically and clinically significant differences, with gains maintained at 3 months posttreatment. Both completer and intention-to-treat analyses found ACT and CBT to produce similar outcomes. There was some support for ACT having greater effect sizes for QOL outcomes but not for avoidance/fusion. Although this study does not suggest that ACT is equivalent to CBT or should be adopted in its place, it does provide evidence that ACT might be another empirically supported treatment option for anxious youth. Further research is needed to replicate these findings.]]> Wed 22 Jan 2020 12:13:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:30968 Wed 19 Jan 2022 15:15:50 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:35734 2, 203) = 8.13, p = 0.003; patient functioning, F(_{2, 203}) = 6.01, p = 0.008] and reductions in duration of hospitalizations [F(_{2, 203}) = 6.51, p = 0.005] over the 4-year follow-up. There were not any significant increases of medication dosages or service use by both the family support and psycho-education groups over time. Conclusions: The peer-led family support group can be an effective psychosocial intervention in early psychosis indicating long-term benefits on both patient and family functioning and re-hospitalizations.]]> Wed 13 Nov 2019 12:13:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:26875 Wed 11 Apr 2018 17:19:54 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:2177 Wed 11 Apr 2018 17:19:37 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:25389 Wed 11 Apr 2018 17:04:48 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:2532 Wed 11 Apr 2018 16:37:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:14162 Wed 11 Apr 2018 16:05:43 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:6811 Wed 11 Apr 2018 15:33:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:18907 Wed 11 Apr 2018 15:25:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:22705 n=174) were randomly allocated to the face-to-face, group-based intervention (six, theory-based two-hour sessions delivered over 8weeks targeting healthy eating and physical activity [PA]) or wait-list control (after completion of 20-week data collection). Assessment of the primary outcome (pedometer-assessed mean daily step counts) and secondary outcomes (diet and alcohol intake [Food Frequency Questionnaire], self-reported PA, weight, body mass index, and waist circumference) were assessed at baseline, 8-and 20-weeks. Results: There was a significant difference between the change over time in the intervention group and the control group. At 20weeks, the intervention group had increased by 478 steps, and the control group had decreased by 1282 steps; this represented an adjusted mean difference of 1761 steps (184 to 3337; P=0.0028). Significant intervention effects for secondary outcomes, included a half serving increase in vegetable intake (difference 39g/day; 95% CI: 12 to 67; P=0.02), weight loss (kg) (difference -1.5kg; 95% CI, -2.6 to -0.3; P=0.014) and change in body mass index (kg/m2) (difference -0.55kg/m2; 95% CI, -0.97 to -0.13; P=0.012). No significant intervention effects were found for self-reported PA, total sitting time, waist circumference, fruit, energy, fibre, alcohol, meat, or fat consumption. Conclusions: The ENRICH intervention was effective for improving PA, weight, body mass index, and vegetable consumption even with the inclusion of multiple cancer types and carers. As an example of successful research translation, the Cancer Council NSW has subsequently adopted ENRICH as a state-wide program. Trial registration: Australian New Zealand Clinical Trials Register identifier: ANZCTRN1260901086257.]]> Wed 11 Apr 2018 15:23:38 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:1315 Wed 11 Apr 2018 14:45:43 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:21003 Wed 11 Apr 2018 14:29:48 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:26221 Wed 11 Apr 2018 13:11:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:28361 d=0.45) and help-seeking intentions (RR 1.17; d=0.32), with help seeking increasing for the intervention group and declining for the control group. There were also significant interactions for days completely (RR 0.50) and partially (RR 0.74) out of role favoring the intervention group. However, 37% (30/81) of the intervention group did not complete even 1 module. Conclusions: This self-guided Web-based intervention encouraged help seeking associated with ATS use and reduced days out of role, but it did not reduce ATS use. Thus, this program provides a means of engaging with some sections of a difficult-to-reach group to encourage treatment, but a substantial minority remained disengaged.]]> Wed 11 Apr 2018 12:55:00 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:30123 Wed 11 Apr 2018 12:41:28 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:10514 Wed 11 Apr 2018 11:31:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:29252 p = .019) and Week-4 (83 vs 75 nmol/L; p = .030) in the Active-group, but not at Week-26. At week-4, there were no differences in 2.4 m gait-velocity (0.42 m/s vs 0.39 m/s, p = .490), fractures (2.7 % vs 2.8 %, p = .964) but Active participants reported less falls (6.3 % vs 21.1 %, χ² = 4.327; p = 0.024), with no significant reduction in deaths at week-4 (1 vs 3, p = 0.295), higher percentage reporting ‘no pain or discomfort’ (96.4 % vs 88.8 %, p = 0.037), and trended for higher EuroQoL-scores (p = 0.092) at week-26. One case of hypercalcemia at week-2 normalised by week-4. Conclusion: Among older people after hip fracture surgery, the REVITAHIP strategy is a safe and low cost method of improving vitamin-D levels, reducing falls and pain levels.]]> Wed 11 Apr 2018 11:18:26 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:22217 Cochrane Central Register of Controlled Trials) (all years), EMBASE (1974 -), MEDLINE (1950 -) and PsycINFO (1967 -). We also checked reference lists of relevant studies and reviews. We applied no date or language restrictions. Selection criteria: All randomised controlled trials of psychological therapies compared to a control, pharmacological therapy or other treatments in children or adolescents exposed to a traumatic event or diagnosed with PTSD. Data collection and analysis: Two members of the review group independently extracted data. If differences were identified, they were resolved by consensus, or referral to the review team. We calculated the odds ratio (OR) for binary outcomes, the standardised mean difference (SMD) for continuous outcomes, and 95% confidence intervals (CI) for both, using a fixed-effect model. If heterogeneity was found we used a random-effects model. Main results: Fourteen studies including 758 participants were included in this review. The types of trauma participants had been exposed to included sexual abuse, civil violence, natural disaster, domestic violence and motor vehicle accidents. Most participants were clients of a trauma-related support service. The psychological therapies used in these studies were cognitive behavioural therapy (CBT), exposure-based, psychodynamic, narrative, supportive counselling, and eye movement desensitisation and reprocessing (EMDR). Most compared a psychological therapy to a control group. No study compared psychological therapies to pharmacological therapies alone or as an adjunct to a psychological therapy. Across all psychological therapies, improvement was significantly better (three studies, n = 80, OR 4.21, 95% CI 1.12 to 15.85) and symptoms of PTSD (seven studies, n = 271, SMD -0.90, 95% CI -1.24 to -0.42), anxiety (three studies, n = 91, SMD -0.57, 95% CI -1.00 to -0.13) and depression (five studies, n = 156, SMD -0.74, 95% CI -1.11 to -0.36) were significantly lower within a month of completing psychological therapy compared to a control group. The psychological therapy for which there was the best evidence of effectiveness was CBT. Improvement was significantly better for up to a year following treatment (up to one month: two studies, n = 49, OR 8.64, 95% CI 2.01 to 37.14; up to one year: one study, n = 25, OR 8.00, 95% CI 1.21 to 52.69). PTSD symptom scores were also significantly lower for up to one year (up to one month: three studies, n = 98, SMD -1.34, 95% CI -1.79 to -0.89; up to one year: one study, n = 36, SMD -0.73, 95% CI -1.44 to -0.01), and depression scores were lower for up to a month (three studies, n = 98, SMD -0.80, 95% CI -1.47 to -0.13) in the CBT group compared to a control. No adverse effects were identified. No study was rated as a high risk for selection or detection bias but a minority were rated as a high risk for attrition, reporting and other bias. Most included studies were rated as an unclear risk for selection, detection and attrition bias. Authors' conclusions: There is evidence for the effectiveness of psychological therapies, particularly CBT, for treating PTSD in children and adolescents for up to a month following treatment. At this stage, there is no clear evidence for the effectiveness of one psychological therapy compared to others. There is also not enough evidence to conclude that children and adolescents with particular types of trauma are more or less likely to respond to psychological therapies than others. The findings of this review are limited by the potential for methodological biases, and the small number and generally small size of identified studies. In addition, there was evidence of substantial heterogeneity in some analyses which could not be explained by subgroup or sensitivity analyses. More evidence is required for the effectiveness of all psychological therapies more than one month after treatment. Much more evidence is needed to demonstrate the relative effectiveness of different psychological therapies or the effectiveness of psychological therapies compared to other treatments. More details are required in future trials in regards to the types of trauma that preceded the diagnosis of PTSD and whether the traumas are single event or ongoing. Future studies should also aim to identify the most valid and reliable measures of PTSD symptoms and ensure that all scores, total and sub-scores, are consistently reported.]]> Wed 11 Apr 2018 10:51:20 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:13780 Wed 11 Apr 2018 10:43:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:39815 I² statistic. This systematic review was registered with PROSPERO (CRD42018089279) and the protocol is published. Results: The search yielded 11,640 studies. Subsequent to removing duplicates, 9657 studies were screened at title and abstract stage and 1456 were assessed at full-text stage. Eighteen studies met criteria for inclusion in this review. Meta-analysis did not reveal a significant difference between groups for treatment outcome (standardised mean difference 0.22 [-0.09, 0.54]; I²: 69%, p=0.17) and remission (risk ratio 0.84 [0.64, 1.11]; I²: 51%, p=0.22). Limitations: This review was limited by lack of studies on bipolar disorder. Conclusion: PD comorbidity does not appear to affect treatment efficacy of pharmacological interventions for adults with mood disorders.]]> Wed 10 Aug 2022 13:16:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:35767 Wed 09 Aug 2023 09:54:41 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:34516 Wed 08 Jan 2020 11:22:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:37065 Wed 06 Apr 2022 14:03:21 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:22451 Wed 05 Dec 2018 17:46:53 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:33578 Wed 04 Sep 2019 09:48:09 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:31148 Wed 02 Oct 2019 10:20:23 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:38903 Wed 02 Mar 2022 12:13:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:22631 Tue 31 Jul 2018 13:12:15 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:47603 18 years of age undergoing RSI in the ED of two hospitals in New South Wales, Australia, were randomly assigned to receive measured CP using weighing scales to target the ideal CP range (3.060-4.075 kg) or control CP where the weighing scales were used, but the CP operator was blinded to the amount of CP applied during the RSI. A data logger recorded all CP delivered during each RSI. Immediately after intubation, tracheal and esophageal samples were taken and underwent pepsin analysis. Results: Fifty-four RSIs were analyzed (25 measured/29 control). Macroscopic contamination of the larynx at RSI was observed in 14 patients (26%). During induction (0-50 seconds), both groups delivered in-range CP. During intubation (51-223 seconds), laryngoscopy was associated with a reduction in mean CP below 3.060 kg in both groups. When compared, there was no statistically significant difference between the groups. For 11 patients, pepsin was detected in the oropharyngeal sample, while three were positive for tracheal pepsin. Seven patients (four control/three measured) were treated for clinical aspiration during hospitalization. As a result of the finding that neither group could maintain ideal range CP during laryngoscopy, the trial was abandoned. Conclusion: Laryngoscopy provides a counter force to CP, which is negated to facilitate tracheal intubation. The concept that a static 3.060 to 4.075 kg CP could be maintained during laryngoscopy and intubation was rejected by our study. Whether a lower CP range could prevent aspiration during RSI was not explored by this study.]]> Tue 24 Jan 2023 09:43:33 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:15512 Tue 24 Aug 2021 14:34:54 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:4805 Tue 18 Oct 2022 22:09:05 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:21585 Tue 17 Nov 2015 14:40:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:43085 Tue 13 Sep 2022 12:19:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:25049 Thu 28 Oct 2021 13:05:05 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:41204 Thu 28 Jul 2022 11:26:39 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:29099 Thu 26 Jul 2018 13:15:45 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:405 Thu 25 Jul 2013 09:09:51 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:44934 Thu 25 Jan 2024 14:56:51 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:48103 Thu 25 Jan 2024 13:38:59 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:44701 Thu 20 Oct 2022 15:58:29 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:34235 Thu 13 Jan 2022 10:31:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:25806 Thu 09 Dec 2021 11:04:43 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:24232 Thu 09 Dec 2021 10:12:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:46986 Thu 06 Jul 2023 15:13:05 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:14026 Sat 24 Mar 2018 10:38:31 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:8263 Sat 24 Mar 2018 08:40:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:7111 Sat 24 Mar 2018 08:34:09 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:1977 Sat 24 Mar 2018 08:33:14 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:1713 50% reduction in disability were glucose-lignocaine: 0.42 versus saline 0.36 and exercise: 0.36 versus normal activity: 0.38. There were no between group differences in any of the above measures. Conclusions. In chronic nonspecific low-back pain, significant and sustained reductions in pain and disability occur with ligament injections, irrespective of the solution injected or the concurrent use of exercises.]]> Sat 24 Mar 2018 08:27:38 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:1707 Sat 24 Mar 2018 08:27:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:12428 .05). Some metabolic outcomes improved at 24 months, although there were no between-group differences (P > .05). Conclusions: A reduction in BMI z score was sustained at 24 months by treatment with either program combination. The greatest effects were achieved through inclusion of a parent-centered diet program, indicating the importance of targeting parents within treatment and the possibility of targeting them exclusively in treating obese prepubertal children.]]> Sat 24 Mar 2018 08:17:46 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:10037 Sat 24 Mar 2018 08:12:00 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:10227 Sat 24 Mar 2018 08:11:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:10460 Sat 24 Mar 2018 08:09:11 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:20456 Sat 24 Mar 2018 08:06:57 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:20786 Sat 24 Mar 2018 08:06:01 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:21430 Sat 24 Mar 2018 08:05:48 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:18153 Sat 24 Mar 2018 08:04:42 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:18211 Sat 24 Mar 2018 08:04:37 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:16921 Sat 24 Mar 2018 08:00:32 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:20092 Sat 24 Mar 2018 08:00:08 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:19777 Sat 24 Mar 2018 07:56:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:19227 Sat 24 Mar 2018 07:54:54 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:5226 Sat 24 Mar 2018 07:44:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:27840 Sat 24 Mar 2018 07:41:16 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:29906 P=0.42) and vegetable (P=0.17) intakes between HCFV and LCFV groups. Dietary alpha carotene, beta carotene, lutein, and beta cryptoxanthin intakes were significantly different between the two groups (P<0.01). Following HCFV there was a significantly greater increase in skin yellowness (b*) in both sun-exposed (P<0.001) and unexposed areas, (P<0.001), with no change in skin lightness (L*) or redness (a*). Significantly higher plasma alpha carotene (P=0.004), beta carotene (P=0.001), and lutein (P=0.028) concentrations were found following the HCFV intervention. Skin yellowness correlated with alpha carotene and beta carotene. Conclusions: Skin yellowness (b*) and fasting plasma carotenoid concentrations were significantly higher following HCFV than LCFV over 4 weeks.]]> Sat 24 Mar 2018 07:40:58 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:27016 Sat 24 Mar 2018 07:30:17 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:25691 Sat 24 Mar 2018 07:28:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:25909 Sat 24 Mar 2018 07:27:52 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:27058 Sat 24 Mar 2018 07:25:21 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:4924 Sat 24 Mar 2018 07:21:13 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:23074 Sat 24 Mar 2018 07:12:27 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:25030 Sat 24 Mar 2018 07:10:49 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:24076 Sat 24 Mar 2018 07:09:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:38337 Mon 30 Aug 2021 12:22:50 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:51102 Mon 21 Aug 2023 14:53:16 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:44180 Mon 10 Oct 2022 10:34:22 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:38520 Mon 09 May 2022 16:19:34 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:54097 Mon 05 Feb 2024 09:35:15 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:12881 Mon 03 Sep 2018 12:55:00 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:45466 n = 114 participants with completed cognitive outcomes at follow up were included in this analysis. Using the Cogstate Brief Battery, the following cognitive outcomes were assessed: psychomotor function, attention, visual learning and memory (visual and working). Subgroup analyses investigated whether baseline clinical parameters (baseline cognitive functioning, illness severity and duration, depressive symptoms) moderated the relationship between mangosteen pericarp extract intervention and change in cognitive outcomes. Results: There were no significant between-group changes in any cognitive outcomes assessed. Subgroup analysis based on baseline cognition and clinical characteristics did not reveal any significant between-group difference in change. Conclusions: Mangosteen pericarp extract did not affect cognitive outcomes in people with schizophrenia. Further investigation regarding optimal dosing strategies for mangosteen interventions and the testing of additional cognitive domains may be warranted.]]> Fri 28 Oct 2022 14:45:19 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:37192 Fri 28 Aug 2020 15:51:43 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:53068 Fri 17 Nov 2023 12:08:30 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:48460 .05) in the number of MoodGYM modules completed between the two groups. Discussion and conclusion: The current trial found no benefit to providing a brief online intervention for hazardous alcohol consumption alongside one for depression among people experiencing these co-occurring disorders. Further, the finding that adding an online intervention for drinking to one for depression led to a small reduction in the number of times the interventions were accessed implies the need for caution when deciding how best to provide online help to those with co-occurring depression and hazardous alcohol consumption. Trial Registration: ClinicalTrials.gov NCT03421080.]]> Fri 17 Mar 2023 12:07:36 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:48918 Fri 14 Apr 2023 16:20:17 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:38253 Fri 03 Sep 2021 14:46:19 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:37036 Fri 03 Dec 2021 10:32:41 AEDT ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:51361 Fri 01 Sep 2023 13:41:53 AEST ]]> https://nova.newcastle.edu.au/vital/access/manager/Repository/uon:51360 Fri 01 Sep 2023 13:41:32 AEST ]]>